Roth Capital Maintains Buy on Imax, Raises Price Target to $50

Benzinga Newsdesk www.benzinga.com Positive 58.5%

Neg 0% Neu 0% Pos 58.5%

Roth Capital analyst Eric Handler maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $48 to $50.

Comments

No comments yet. Be the first!